The 22RV1 prostate cancer cell line possesses activation of the MEK/ERK pathway [23], while the ENZ-resistant MR49C and MR49F are recognized to be more dependent on the AKT pathway [24]. The gene discussed is AKT1; the disease is prostate cancer.